AGD

Synchrony Extends Partnership with Affordable Care Offering CareCredit to Patients

Retrieved on: 
목요일, 5월 2, 2024

STAMFORD, Conn., May 2, 2024 /PRNewswire/ -- Synchrony (NYSE: SYF), a consumer financial services company, today announced a multi-year renewal with Affordable Care, LLC., one of America's leading consumer retail healthcare companies supporting dental practices exclusively focused on tooth replacement solutions. Under the expanded agreement, CareCredit, Synchrony's health and wellness credit card, will be offered as a payment option at more than 450 affiliated Affordable Dentures & Implants, DDS Dentures + Implant Solutions and Advanced Dental Implant Center dental practices across 43 states, enabling customers to finance dental implants and denture products to transform their smiles and lives.

Key Points: 
  • Synchrony's Dental Lifetime of Care study found that 58% of respondents believe dental care is not affordable, which may be the reason why the majority of respondents (92%) said they would consider holding off on general dental care because of cost.
  • Financing solutions, such as the CareCredit credit card can help offset the cost burden and empower patients to get the care they need and want.
  • "CareCredit makes it possible for more patients to get the care they desperately need and richly deserve."
  • Additionally, CareCredit offers resources and tools to help educate patients on dental costs and the financing solutions available to plan and pay for care.

Synchrony Expands Dental Payment Offerings with Adit Practice Management Software Partnership

Retrieved on: 
목요일, 4월 18, 2024

STAMFORD, Conn., April 18, 2024 /PRNewswire/ -- Today, Synchrony (NYSE: SYF), a consumer financial services company, announced a new partnership with Adit, an industry leading dental practice management software provider. Increasingly, dentists are looking for external support to deliver patient financing while ensuring patients are getting the experience they want and financial support they need.1

Key Points: 
  • Partnership Extends CareCredit Access to Dental Practices Nationwide and Includes Integration with "Adit Pay" for Patients;
    STAMFORD, Conn., April 18, 2024 /PRNewswire/ -- Today, Synchrony (NYSE: SYF), a consumer financial services company, announced a new partnership with Adit, an industry leading dental practice management software provider.
  • This new partnership with Adit will integrate CareCredit into " Adit Pay ," which allows dental practices to offer CareCredit as a financing option to their patients in a seamless and easy to use way.
  • "Our partnership with Synchrony to integrate CareCredit's offerings into our technology is just another way we can strengthen that foundation for providers."
  • CareCredit is integrated in top dental practice management software solutions, making it easy for dental teams to offer to patients and for patients to apply.

Cambridge GaN Devices Moves to Support Industrial Applications With Higher Power Reference Designs and Demos

Retrieved on: 
화요일, 2월 27, 2024

Cambridge GaN Devices (CGD) , the fabless, clean-tech semiconductor company that develops energy-efficient GaN-based power devices that make greener electronics possible, is addressing higher power industrial applications with its ICeGaN™ technology which has already proved itself rugged, reliable and easy-to-use in high volume consumer devices.

Key Points: 
  • Cambridge GaN Devices (CGD) , the fabless, clean-tech semiconductor company that develops energy-efficient GaN-based power devices that make greener electronics possible, is addressing higher power industrial applications with its ICeGaN™ technology which has already proved itself rugged, reliable and easy-to-use in high volume consumer devices.
  • At the APEC 2024, IEEE Applied Power Electronics Conference and Exposition, the company is introducing new reference designs and showing demos which address the broad and diverse industrial market.
  • Andrea Bricconi | Chief Commercial Officer, CGD
    “We are acutely aware of the increasing power requirements of industrial applications, and the need for high efficiency.
  • This is the first time the company has used a 100% GaN power transistor design for both the power stage and the amplifier.

The Alliance for Genomic Discovery welcomes Bristol Myers Squibb, GSK, and Novo Nordisk

Retrieved on: 
목요일, 1월 4, 2024

SAN DIEGO, Jan. 4, 2024 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, in collaboration with Nashville Biosciences, LLC (NashBio), a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center (VUMC), today announced three new members of the Alliance for Genomic Discovery (AGD).

Key Points: 
  • Bristol Myers Squibb (BMS), GSK and Novo Nordisk join founding member organizations AbbVie, Amgen, AstraZeneca, Bayer, and Merck.
  • Together the pharma members will co-fund the whole-genome sequencing (WGS) of 250,000 DNA samples and have access to the resulting data for use in drug discovery and therapeutic development.
  • "This rich dataset will enable the discovery of highly actionable therapeutic targets and improve the speed, probability of success, and efficiency of the discovery and development process."
  • This release contains forward-looking statements that involve risks and uncertainties, including the expectation for lower costs related to the storing and managing of genomic data costs.

Knightscope Begins Selling Automated Gunshot Detection

Retrieved on: 
수요일, 11월 29, 2023

Knightscope, Inc. [Nasdaq: KSCP] (“Knightscope” or the “Company”), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, today announced the commencement of sales for its Automated Gunshot Detection (“AGD”) systems for both indoor and outdoor environments.

Key Points: 
  • Knightscope, Inc. [Nasdaq: KSCP] (“Knightscope” or the “Company”), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, today announced the commencement of sales for its Automated Gunshot Detection (“AGD”) systems for both indoor and outdoor environments.
  • View the full release here: https://www.businesswire.com/news/home/20231129468651/en/
    Knightscope Begins Selling Automated Gunshot Detection (Graphic: Business Wire)
    Knightscope’s AGD is completely automated with precision localization that can locate shots in both the horizontal and vertical planes (location and elevation), dramatically reducing police and security response times to help expedite the resolution of active shooter threats.
  • Knightscope believes that an on-site, hyper-focused, real-time system is significantly more effective than attempting a city-wide approach over vast areas.
  • Request a demo of Knightscope’s Automated Gunshot Detection, Autonomous Security Robots, and Blue Light Emergency Communication Systems now at www.knightscope.com/discover .

welcomes reforms critical to Australia’s privacy future

Retrieved on: 
금요일, 9월 29, 2023

“This is a vital set of proposals that will deliver significant gains for the Australian community,” Australian Information Commissioner and Privacy Commissioner Angelene Falk said.

Key Points: 
  • “This is a vital set of proposals that will deliver significant gains for the Australian community,” Australian Information Commissioner and Privacy Commissioner Angelene Falk said.
  • “As the privacy regulator, it is pleasing to see support for the positive obligation that personal information handling is fair and reasonable, as a new keystone of the Australian privacy framework,” Commissioner Falk said.
  • “Key developments include enabling individuals to exercise new privacy rights and take direct action in the courts if their privacy is breached.
  • The proposed privacy reforms follow the passing in November 2022 of the Privacy Legislation Amendment (Enforcement and Other Measures) Bill 2022, which introduced significantly increased penalties for serious and repeated privacy breaches and greater powers for the OAIC to resolve breaches.

The Inner Circle Acknowledges, Miriam Dani, MBA, DDS as a Top Pinnacle Professional for her contributions to the field of Dentistry

Retrieved on: 
금요일, 9월 15, 2023

KENILWORTH, Ill., Sept. 15, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Miriam Dani, MBA, DDS, is acknowledged as a Top Pinnacle Professional for her contributions to the field of Dentistry.

Key Points: 
  • KENILWORTH, Ill., Sept. 15, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Miriam Dani, MBA, DDS, is acknowledged as a Top Pinnacle Professional for her contributions to the field of Dentistry.
  • The doctor is considered an expert in comprehensive dentistry; sleep apnea; full mouth restoration; Invisalign; implants; and general family practice.
  • She is dedicated to providing the latest advancements in her field and is a member of CDS; ADA; AGD; and AADSM.
  • Dr. Dani was honored to be invited to the People to People program for Women In Dentistry to China.

Specialty1 Partners Endorses Synchrony's CareCredit Credit Card as the Premier Patient Financing Solution for Dental Surgery Procedures

Retrieved on: 
화요일, 8월 29, 2023

STAMFORD, Conn., Aug. 29, 2023 /PRNewswire/ -- Synchrony (NYSE: SYF), a leading consumer financing company, and Specialty1 Partners, the market leader in specialty dental practice support services, today announced a five-year partnership, making Synchrony's CareCredit health and wellness credit card the premier financing solution for the network of more than 225 endodontic, periodontic and oral surgery offices nationwide which are supported by Specialty1 Partners.

Key Points: 
  • Our partnership with Specialty1 means that more patients will now have options to pay for the treatment plan the specialist recommends."
  • This partnership is central to Specialty1 Partners' doctor-founded, doctor-led vision of helping dental surgical practices optimize their operations and elevate patient care.
  • CareCredit is integrated in more than 80% of all dental practice management software solutions, making it easy for dental teams to accept and for patients to apply.
  • CareCredit has a wide range of financing options available on qualifying purchases, from 6 to 60 months, for treatment sizes small to large.

The Inner Circle Acknowledges, Robert Wunsc as a Top Pinnacle Healthcare Professional for his contributions to the field of Dentistry

Retrieved on: 
금요일, 8월 25, 2023

WYOMISSING, Pa., Aug. 24, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Robert Wunsch is acknowledged as a Top Pinnacle Healthcare Professional for his contributions to the field of Dentistry.

Key Points: 
  • WYOMISSING, Pa., Aug. 24, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Robert Wunsch is acknowledged as a Top Pinnacle Healthcare Professional for his contributions to the field of Dentistry.
  • He pursued higher education at Albright College and continued competing at the collegiate level.
  • The doctor then attended Temple University Maurice H. Kornberg School of Dentistry in 1991 and completed a residency at Community General Hospital from 1991 until 1992.
  • Dentists like Dr. Wunsch and his team, diagnose and treat dental issues and help patients develop better oral hygiene regimens.

The Alliance for Genomic Discovery announces founding biopharma members: AbbVie, Amgen, AstraZeneca, Bayer, and Merck

Retrieved on: 
화요일, 7월 18, 2023

SAN DIEGO, July 18, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, in collaboration with Nashville Biosciences, LLC, a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center (VUMC), today announced the five founding members of the Alliance for Genomic Discovery (AGD). The multiyear agreement aims to accelerate development of therapeutics through large-scale genomics and the establishment of a preeminent clinical genomic resource. Member organizations AbbVie, Amgen, AstraZeneca, Bayer, and Merck will co-fund the whole-genome sequencing (WGS) of 250,000 samples and have access to the resulting data for use in drug discovery and therapeutic development. 

Key Points: 
  • The multiyear agreement aims to accelerate development of therapeutics through large-scale genomics and the establishment of a preeminent clinical genomic resource.
  • Member organizations AbbVie, Amgen, AstraZeneca, Bayer, and Merck will co-fund the whole-genome sequencing (WGS) of 250,000 samples and have access to the resulting data for use in drug discovery and therapeutic development.
  • "We are thrilled to welcome these esteemed companies as the founding cohort in the Alliance for Genomic Discovery," said Joydeep Goswami, chief financial officer and chief strategy and corporate development officer of Illumina.
  • With today's announcement, deCODE genetics, a wholly owned subsidiary of Amgen, will sequence the remaining samples for the Alliance.